Skip to main content
. 2020 Apr 7;12(4):234. doi: 10.3390/toxins12040234

Table 2.

Association between patient characteristics and protein-bound uremic toxin concentrations at baseline.

Characteristic Kynurenine (µmol/L)* Kynurenic Acid (µmol/L)* Indoxyl Sulfate (µmol/L)* Indole-3-Acetic Acid (µmol/L)* p-Cresyl Sulfate tertiles p-Cresyl Glucuronide (µmol/L)* Hippuric Acid (µmol/L)*
β (p) β (p) β (p) eβ (p) eβ (p) eβ (p) eβ (p)
Age (years) −0.003 (0.808) −0.020 (0.020) −0.167 (0.754) 1.000 (0.976) 1.010 (0.531) 1.001 (0.895) 1.001 (0.899)
Gender (male = 1) 0.203 (0.514) 0.356
(0.145)
3.750
(0.802)
1.180 (0.309) 1.784 (0.179) 0.668 (0.182) 1.062 (0.726)
Renal creatinine clearance (mL/min/1.73m2) −0.019 (0.514) −0.115 (<0.001) −6.024 (0.001) 0.958 (0.024) 1.002 (0.968) 0.899 (0.004) 0.898 (<0.001)
nPNA (g/kg/d) −1.579 (0.055) 2.367 (<0.001) 110.055 (0.005) 0.852 (0.687) 4.242 (0.216) 2.572 (0.236) 1.891 (0.148)
Dialysis vintage (years) −0.096 (0.102) −0.003 (0.951) −0.311 (0.914) 0.950 (0.077) 1.122 (0.187) 1.082 (0.170) 0.984 (0.613)
Albumin (g/L) 0.027 (0.543) 0.054
(0.119)
0.019
(0.993)
1.047 (0.072) 1.216 (0.004) 1.082 (0.065) 1.019 (0.462)
Beta blocker (yes = 1) 0.334 (0.282) 0.418
(0.084)
19.877 (0.184) 0.976 (0.881) 1.507 (0.341) 0.851 (0.594) 1.189 (0.314)
Calcium antagonist (yes = 1) 0.068 (0.833) 0.018
(0.942)
−12.860 (0.407) 1.122 (0.500) 1.084 (0.855) 0.689 (0.231) 0.752 (0.113)
ACE-inhibitor (yes = 1) −0.041 (0.901) −0.550 (0.028) 13.994 (0.374) 0.724 (0.052) 1.443 (0.458) 1.235 (0.505) 0.800 (0.214)
ARB (yes = 1) 0.008 (0.983) 0.653
(0.018)
−16.456 (0.344) 1.065 (0.727) 0.789 (0.595) 0.800 (0.525) 1.337 (0.141)
Statin (yes = 1) 0.039 (0.902) 0.224
(0.359)
3.831
(0.800)
0.705 (0.030) 0.908 (0.823) 1.061 (0.845) 0.800 (0.196)
Furosemide (yes = 1) 0.440 (0.210) −0.685 (0.011) −14.406 (0.399) 1.072 (0.714) 1.770 (0.242) 0.702 (0.301) 1.114 (0.580)
Systolic blood pressure (mmHg) 0.001 (0.857) 0.007
(0.278)
−0.230 (0.547) 0.993 (0.126) 0.988 (0.292) 1.001 (0.862) 1.001 (0.804)
Diastolic blood pressure (mmHg) −0.004 (0.776) 0.010
(0.401)
0.790
(0.277)
0.994 (0.463) 1.016 (0.459) 1.015 (0.319) 1.013 (0.120)
Pulse pressure (mmHg) 0.004 (0.690) 0.006
(0.438)
−0.650 (0.156) 0.993 (0.165) 0.977 (0.088) 0.996 (0.676) 0.997 (0.504)
History of CVD (yes = 1) 0.248 (0.468) 0.069
(0.797)
17.557 (0.286) 0.863 (0.407) 1.842 (0.198) 0.847 (0.617) 0.724 (0.087)
Diabetes mellitus (yes = 1) 0.158 (0.693) 0.624
(0.044)
27.092 (0.159) 1.047 (0.843) 1.322 (0.614) 0.704 (0.367) 1.492 (0.074)
HsCRP (mg/L) −0.001 (0.911) −0.010 (0.177) 0.585
(0.216)
0.999 (0.917) 0.968 (0.076) 0.994 (0.486) 0.999 (0.898)

ACE-inhibitor, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CVD, cardiovascular disease; HsCRP, high-sensitivity C-reactive protein; nPNA, normalized protein nitrogen appearance. * Multivariate linear regression analysis with adjustment for age, gender and renal creatinine clearance. Data are expressed as the unstandardized beta regression coefficient (β) with p-value, significant relations are shown in bold font. The plasma concentration of kynurenine, kynurenic acid and indoxyl sulfate will increase with β, and the plasma concentration of indole-3-acetic acid, p-cresyl glucuronide and hippuric acid, will be multiplied by eβ if the variable increases by 1 unit or if the variable changes from 0 to 1 for a dichotomous variable. Ordinal logistic regression analysis with adjustment for age, gender and creatinine clearance for p-cresyl sulfate tertiles (tertile 1: <337 µmol/L, tertile 2: 337–701 µmol/L, tertile 3: >701 µmol/L). Data are expressed as eβ with p-value which denotes the odds of having a plasma concentration in a higher tertile if the variable increases by 1 unit or changes from 0 to 1 for a dichotomous variable. Significant associations are shown in bold font.